Dailyrep.net
Business

Stock futures slip after Dow retakes record high

Stock futures declined in early trading on Thursday after the blue-chip Dow Jones Industrial Average retook its record high in the prior session amid solid corporate earnings.

Dow futures fell 104 points, or 0.2%. S&P 500 futures shed 0.2% and Nasdaq 100 futures lost 0.2%.

IBM shares lost more than 5% in premarket trading following a revenue miss in the third quarter. Its top two business segments — global services and the Cloud & Cognitive Software business — fell short of estimates.

Tesla shares dipped by 1% in premarket trading even after the electric-car maker posted record earnings and revenue in the third quarter that beat expectations.

The Dow jumped about 150 points to hit an intraday record Wednesday, surpassing its peak from mid-August. It fell just short of its closing record. The S&P 500 climbed 0.4% for its sixth straight positive day and sits just 0.2% below its all-time high. The tech-heavy Nasdaq Composite closed Wednesday’s session slightly lower, however.

Loading chart…

“The Dow traded to a new all-time high today, again showing the resilience of dip buyers and the importance of cyclical companies in the stock market rally,” said Chris Zaccarelli, CIO at Independent Advisor Alliance.

Investors have been monitoring the third-quarter earnings season to assess profit growth as well as signs of cost pressures and supply-chain disruptions for the rest of the year. Of the approximately 70 S&P 500 companies that have reported results so far, 86% posted earnings that topped analysts expectations, according to Refinitiv.

“There are no signs of widespread erosions of margins at the moment. Perhaps there is so much money sloshing about that for now prices are broadly being passed on,” Jim Reid, head of thematic research at Deutsche Bank, said in a note.

Railroad giant CSX jumped more than 3% in extended trading following a stronger-than-expected earnings report.

On Wednesday, the Food and Drug Administration authorized booster shots of both Johnson & Johnson and Moderna’s Covid vaccines, a critical step in distributing extra doses to tens of millions of people. U.S. regulators also approved “mixing and matching” vaccines.

Related posts

World leaders reach landmark deal on a global corporate tax rate

admin

Facebook Engineer Pens Scathing Letter Saying Company Is ‘On The Wrong Side of History’

admin

Amazon Opens Online Pharmacy For Prescription Medication Delivery

admin